Li Xue, Yan Zhifeng, Li Longzhu, Ma Tao, Chen Yang
School of Pharmacy, Bengbu Medical College, Bengbu 233030, China.
School of Public Basic Courses, Bengbu Medical College, Bengbu 233030, China.
Se Pu. 2021 Jun;39(6):599-606. doi: 10.3724/SP.J.1123.2020.11005.
Panax ginseng has a 5000-year-long history as a traditional herbal medicine in Eastern Asia and North America. It is also known as crown jewel in traditional Chinese herbs because of its wide pharmacological properties. Ginsenosides, a class of saponins containing triterpene aglycones and various sugar moieties, are the main active components of ginseng. Considering the low abundance of ginsenosides and other abundant interferences, separation of ginsenosides is essential prior to further analysis. Recently, our group demonstrated the potential of a boronate affinity material for the selective enrichment of ginsenosides. However, conventional boronate affinity materials suffer from an apparent drawback. The binding strength of boronic acids toward -diol-containing compounds is low, with dissociation constants () ranging from 10 to 10mol/L. Thus, it is necessary to develop boronate affinity materials with high binding strength. In this study, we developed polyethyleneimine (PEI)-functionalized boronate affinity magnetic nanoparticles (BA-MNPs) for the selective enrichment of ginsenosides. Branched PEI was applied as a scaffold to amplify the number of boronic acid moieties, while 3-formylphenylboronic acid, which shows high affinity toward -diol-containing molecules, was used as the affinity ligand. In addition, the presence of the multi-glycan structure of ginsenoside leads to higher binding affinity between the PEI-BA-MNPs due to the synergistic multivalent binding effect. Combining with high performance liquid chromatography, a method for the selective analysis of ginsenosides was established. With ginsenoside Re as the representative and under the optimized conditions for magnetic solid-phase extraction, the developed method showed good linearity in the range of 50-800 μg/L, with a linear correlation coefficient () of 0.9681. At different spiked levels (0.1-10 mg/L), the recoveries were in the range of 91.5%-117.3%, and the relative standard deviations (RSDs) ranged from 7.2% to 13.4%. Since the PEI-BA-MNPs exhibited significantly improved binding strength toward ginsenosides, they could extract trace glycoproteins. After enrichment, a 50-fold improvement in the sensitivity was achieved. In addition, the PEI-BA-MNPs maintained at least 72% of their original binding capacity after five consecutive uses. Finally, the developed method was applied to the determination of ginsenoside Re in commercial medicine (Qipi oral liquid). As opposed to the tedious and time-consuming sample preparation in the standard method (Pharmacopoeia of the People's Republic of China, 2015; ChP2015), the present protocol allowed for direct enrichment of the diluted commercial medicine with PEI-BA-MNPs. The magnetic separation made the overall experiment much simpler than the standard ChP2015 method. After washing and elution, the enriched ginsenoside Re was eluted and subjected to HPLC-UV analysis. The results obtained with the developed method (0.27%) were similar to those of ChP2015 (0.31%). We have experimentally demonstrated that PEI-BA-MNPs are ideal affinity sorbents for the selective enrichment of ginsenosides owing to their significant advantages, including high affinity, excellent selectivity, easy manipulation, high binding capacity, and fast binding equilibrium. As many saponins contain sugar side chains, we foresee a promising prospect for the proposed method in real-world applications.
人参作为传统草药在东亚和北美有着5000年的悠久历史。因其广泛的药理特性,它在中国传统草药中也被誉为“皇冠上的明珠”。人参皂苷是一类含有三萜苷元和各种糖基部分的皂苷,是人参的主要活性成分。考虑到人参皂苷含量低且存在大量干扰物,在进一步分析之前,人参皂苷的分离至关重要。最近,我们小组展示了一种硼酸酯亲和材料用于选择性富集人参皂苷的潜力。然而,传统的硼酸酯亲和材料存在明显缺陷。硼酸对含二醇化合物的结合强度较低,解离常数(Kd)范围为10⁻³至10⁻⁵mol/L。因此,有必要开发具有高结合强度的硼酸酯亲和材料。在本研究中,我们开发了聚乙烯亚胺(PEI)功能化的硼酸酯亲和磁性纳米颗粒(BA-MNPs)用于选择性富集人参皂苷。支化PEI用作支架以增加硼酸基团的数量,而对含二醇分子具有高亲和力的3-甲酰基苯硼酸用作亲和配体。此外,人参皂苷的多聚糖结构的存在由于协同多价结合效应导致PEI-BA-MNPs之间具有更高的结合亲和力。结合高效液相色谱,建立了一种人参皂苷的选择性分析方法。以人参皂苷Re为代表,在磁性固相萃取的优化条件下,所开发的方法在50 - 800μg/L范围内具有良好的线性,线性相关系数(r)为0.9681。在不同加标水平(0.1 - 10mg/L)下,回收率在91.5% - 117.3%范围内,相对标准偏差(RSD)范围为7.2%至13.4%。由于PEI-BA-MNPs对人参皂苷表现出显著提高的结合强度,它们可以提取痕量糖蛋白。富集后,灵敏度提高了50倍。此外,PEI-BA-MNPs在连续使用五次后仍保持至少72%的原始结合能力。最后,所开发的方法应用于市售药品(启脾口服液)中人参皂苷Re的测定。与标准方法(《中华人民共和国药典》,2015年版;ChP2015)中繁琐且耗时的样品制备不同,本方案允许用PEI-BA-MNPs直接富集稀释后的市售药品。磁性分离使整个实验比标准的ChP2015方法简单得多。洗涤和洗脱后,富集的人参皂苷Re被洗脱并进行HPLC-UV分析。所开发方法得到的结果(0.27%)与ChP2015(0.31%)相似。我们通过实验证明,PEI-BA-MNPs因其显著优势,包括高亲和力、优异的选择性、易于操作、高结合容量和快速的结合平衡,是选择性富集人参皂苷的理想亲和吸附剂。由于许多皂苷含有糖侧链,我们预见到该方法在实际应用中具有广阔的前景。